Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E G Bridges

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Antimicrobial Agents and Chemotherapy|July 14, 1998
Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitroG E Dutschman, E G Bridges, S H Liu, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 21, 2003
Monoval-LdC: efficient prodrug of 2'-deoxy-beta-L-cytidine (L-dC), a potent and selective anti-HBV agentS Benzaria, C Pierra, D Bardiot, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Pharmacology of beta-L-thymidine and beta-L-2'-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virusB Hernandez-Santiago, L Placidi, E Cretton-Scott, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
Anti-HBV specific beta-L-2'-deoxynucleosidesM L Bryant, E G Bridges, L Placidi, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Antiviral L-nucleosides specific for hepatitis B virus infectionM L Bryant, E G Bridges, L Placidi, et al.
Antiviral Chemistry & Chemotherapy|October 12, 2001
Antiviral beta-L-nucleosides specific for hepatitis B virus infectionD N Standring, E G Bridges, L Placidi, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Antimicrobial Agents and Chemotherapy|July 14, 1998
Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitroG E Dutschman, E G Bridges, S H Liu, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 21, 2003
Monoval-LdC: efficient prodrug of 2'-deoxy-beta-L-cytidine (L-dC), a potent and selective anti-HBV agentS Benzaria, C Pierra, D Bardiot, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2002
Pharmacology of beta-L-thymidine and beta-L-2'-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virusB Hernandez-Santiago, L Placidi, E Cretton-Scott, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
Anti-HBV specific beta-L-2'-deoxynucleosidesM L Bryant, E G Bridges, L Placidi, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Antiviral L-nucleosides specific for hepatitis B virus infectionM L Bryant, E G Bridges, L Placidi, et al.
Antiviral Chemistry & Chemotherapy|October 12, 2001
Antiviral beta-L-nucleosides specific for hepatitis B virus infectionD N Standring, E G Bridges, L Placidi, et al.
Pageof 2